Customers are responsible for paying all customs duties, taxes, and tariffs levied for importation of PMRJ Reference Standards.

医薬品・医療機器・再生医療等製品の承認審査・安全対策・健康被害救済の3つの業務を行う組織。

PMRJ produces and distributes compendial reference standards represented by the Japanese Pharmacopoeia Reference Standards.

The 16th Edition of the JP was promulgated by Ministerial Notification No. 65 of the Ministry of Health, Labour and Welfare (MHLW) on March 24, 2011. In July 2011, the Committee on JP established the basic principles for the preparation of the JP 17th Edi-tion, setting out the roles and characteristics of the JP,

Please visit PMRJ Pharmaceutical Reference Standards Center website <https://www.pmrj-rs.jp/en> to check the ordering instruction. In addition, please find a leaflet of each reference …

JP XVIII THE JAPANESE PHARMACOPOEIA EIGHTEENTH EDITION Official from June 7, 2021 English Version THE MINISTRY OF HEALTH, LABOUR AND WELFARE

Pharmaceutical and Medical Device Regulatory Science Society of Japan (PMRJ) is a non-profit general incorporated foundation formerly known as Society of Japanese Pharmacopoeia established in June 1956. Our mission is to promote better quality, efficacy, and safety of drugs and medical devices by advancing their regulatory sciences. new !

医薬品・医療機器・再生医療等製品の承認審査・安全対策・健康被害救済の3つの業務を行う組織。

The Japanese Pharmacopoeia Reference Standards are reference standards used for the tests of drugs specified in the Japanese Pharmacopoeia and for the General Tests.

JPTI provides technical information helping users to obtain accurate and reproducible results of the tests described in the JP. * The Japanese Pharmaceutical Codex 2002 (JPC2002; in Japanese) * Japanese Orange Books (Approved drug products with therapeutic equivalence evaluations ; in Japanese)